Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Plaque Psoriasis × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 5 Psoriasis 2 Spondylitis, Ankylosing 1 Sarcoidosis 1 Plaque Psoriasis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Inflammation 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Crohn Disease 1 Colitis, Ulcerative 1 Arthritis, Psoriatic 1

Interventions

Adalimumab 1 ABP 501 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05073315 2024-02-09

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Amgen

Phase 3 Completed

425 enrolled 22 charts

Plaque Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡